Thursday, November 30, 2023, 8-10:00 AM,

Smilow Cancer Hospital, New Haven, CT

Register today at: 

Despite coverage being available, lung cancer screenings are not widely employed for several reasons—with only about a 6% utilization rate in CT. Join us as we explore the challenges we continue to face, ensuring lung cancer screening becomes a public health priority and providing the public with safe opportunities to prevent cancer or detect it early to improve patient outcomes.

The following Speakers are  confirmed for the Forum:

  • Roy Herbst, MD, PhD- Deputy Director, Yale Cancer Center; Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital
  • Lynn Tanoue, MD, MBA – Director of the Lung Cancer Screening and Nodule Program at Smilow Cancer Hospital
  • Brian B. Whang, FACS– Medical Director, Lung Screening Program, Hartford HealthCare
  • James WhiteExecutive Director, US Medical Oncology, Lung, Emerging Tumors, & Abraxane, Bristol Myers Squibb
  • Lucinda Hogarty– Executive Director, Connecticut Cancer Partnership
  • Marianne Davies – NP, DNP, MSN, BSN, Lecturer, Yale Cancer Center

Participants will include diverse stakeholders in our communities – patient advocates, payors, health systems, business leaders, providers, patients, and lawmakers.

ACS CAN will use this event to help illustrate and answer the following questions:

  • How significant is the stigma surrounding lung cancer and what is being done to overcome it? What isn’t?
  • How are new programs regarding access to lung cancer detection and referrals being implemented? What challenges remain?
  • What still needs to be done to improve patient access to screenings to improve cancer mortality in Connecticut?
  • What further steps need to be taken regarding education and outreach to communities of color and other populations disproportionately impacted by lung cancer?

Please noteRegistration is required. To register for this event, please go to